Top 50 Life Science Startup Investors in Asia in July 2025
A list of 50 angel investors and VC (Venture Capital) funds that invest in Life science startups based in Asia. We rank investors based on the number of investments they made in Life science companies from Asia. We update this investor list every month.Top 50 Life Science Startup Investors in Asia in July 2025
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
- Medical, Biotechnology, Health Care
- Seed, Funding Round, Series A
- China, United States, United Kingdom
Portfolio highlights
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
- Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
- Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Series B, Series A, Series C
- China, United States, Singapore
Portfolio highlights
- dinii — Dinii is a mobile order platform for take-out shops.
- Ascentium — At Ascentium, we believe in the power of partnership to realise unlimited growth potential.
- Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
We help founders build enduring companies.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- Manus AI — Manus is a general AI agent that turns your thoughts into actions. It excels at various tasks in work and life, getting everything done while you rest.
- Noematrix — Noematrix is an embodied intelligence company that specializes in innovative general robotic intelligence solutions and services.
- Xingkeyuan — Star Science is a high-performance lithium battery silicon-carbon negative electrode material research and development company. It has achieved small-scale mass manufacture of nano-silicon as well as the experimental development of high-efficiency silicon-carbon composite materials.
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series C
- China, United States, Hong Kong
Portfolio highlights
- AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
- LongBio Pharma — LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.
- Tianchen Biotechnology — Tianchen Biotechnology is a biotech company that specializes in the research, design, development, and sales of ophthalmology-related medical products. It provides complete diagnostic and treatment solutions for ophthalmology.
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more
Investment focus
- Information Technology, Software, Health Care
- Funding Round, Series A, Series B
- Japan, United States, Singapore
Portfolio highlights
- LiLz — LiLz is an IT technology network for businesses looking to use AI and IoT to offer new services and value.
- EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
- NABLA Mobility — Solving the complexities involved in the "Operation of Fleets" of Mobility and support its evolution and decarbonization
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series B, Series C
- China, United States, India
Portfolio highlights
- Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
- CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
- Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.
Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology.
The firm was founded in 2014 and based in Osaka, Japan.
Show more
Investment focus
- Biotechnology, Manufacturing, Health Care
- Funding Round, Seed, Series A
- Japan
Portfolio highlights
- Ayumo — Ayumo is a research and development company that provides deep learning services with medical insights and AI technology.
- RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
- EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
UntroD Capital is an R&D-based innovative technology that specializes in social implementation.
Show more
Investment focus
- Manufacturing, Biotechnology, Robotics
- Funding Round, Seed, Series A
- Japan, Singapore, India
Portfolio highlights
- Alternō — Alternō was founded with a vision to create Asia's first low-cost thermal energy storage solution for renewable energy, to be deployed widely across the region by 2050. Alternō received early stage funding from Antler VC in Jan 2023 to kick off the research & development.
- Q5D Technology — Additive manufacturing with conductors. Eliminate traditional wiring, saving space and weight. Unique 5-axis robots add power and data functions to products. Simplify supply chains and manufacturing. Transform productivity with our hardware, software, and support.
- Optieum Biotechnologies — Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers. Their proprietary platform technology, Eumbody System™, enables to develop and detect a scFv-based product candidates that specifically bind to, and modulate tooptimize the immune-cell function for oncology targets.We are committed to helping patients with severe diseases by bringing life-changing therapies to the patients in need.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Germany
Portfolio highlights
- Amazinc — Amazinc is a zinc battery R&D and production company that specializes in zinc battery development and manufacture.Amazinc offering a systematic design of leading zinc-based battery solutions, including energy storage mechanisms, battery materials, and structural design.
- ViGeneron — ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vectorplatform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.
- Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more
Investment focus
- Health Care, Internet, Information Technology
- Funding Round, Seed, Series A
- Japan, United States, Ethiopia
Portfolio highlights
- Blackbox — Blackbox is an entertainment firm that is involved in businesses, including VTuber production, media mix, and live music events.
- Knowhere — Knowhere is a company that applies high-performance AI to sports.
- Linea Innovations — Linea Innovations is an energy production company that develops commercial fusion reactors with advanced fuel technology.
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more
Investment focus
- Software, Health Care, Information Technology
- Funding Round, Series A, Seed
- Japan, United States
Portfolio highlights
- Creatura — Creatura assists companies in reducing greenhouse gas emissions by generating and distributing carbon credits and promoting the adoption of renewable energy sources.
- Upward — UPWARD is highly by linking CRM · schedule map / location information, is a cloud service for the visiting business of field sales easier. Field salespersons who have many customers and who are out of the office feel that it is difficult to grasp all customers to Kampek and measure the timing of visits no matter how memorable they are.
- Tech Doctor — Tech Doctor is a health monitoring service which provides analysis and insights for self care reducing the need for health care workers.
Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.
Show more
Investment focus
- Biotechnology, Software, Manufacturing
- Series A, Series B, Funding Round
- United States, Canada, Spain
Portfolio highlights
- 6K — WHERE INDUSTRY 4.0 MEETS SUSTAINABLE PRODUCTION OF BREAKTHROUGH MATERIALS
- e-Zinc — Founded in 2012, e-Zinc is a Toronto, Canada, based corporation that has developed a breakthrough electrochemical technology for storing energy in zinc metal. This low-cost, flexible, and long-duration energy storage solution will provide the platform for the world’s energy markets to be fully powered by renewable energy, enabling a zero-carbonenergy future.
- CytoTronics — Visualize live cell function at scale for cell biology discovery with Pixel systems. Monitor cell viability, morphology, electrophysiology, metabolism and more.
MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.
Show more
Investment focus
- Artificial Intelligence, Software, Information Technology
- Seed, Angel, Pre-Seed
- China, United States, Singapore
Portfolio highlights
- TestSprite — AI powered fully automated end-to-end testing solutions to help enterprises launch their products faster.
- Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
- Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.
Linear Capital focuses on investment projects in the fields of Data Application, Data Infrastructure and cutting-edge technology applications. they believe that cutting-edge technology is the primary productive force, and they are committed to becoming an important promoter of cutting-edge technology landing industries, realizing FrontierTechnology,
Show more
Investment focus
- Software, Artificial Intelligence, Biotechnology
- Seed, Angel, Series A
- China, Germany, Hong Kong
Portfolio highlights
- Bot Auto — Bot Auto develops and operates autonomous trucks for middle-mile freight.
- TARS — Zhihang Zhong is a prominent researcher in the field of artificial intelligence, particularly known for his work on integrating spatial perception and reasoning into AI systems.
- NewPro — NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible.
ULTIMA is an investment management firm.
Show more
Investment focus
- Hardware, Software, Agriculture
- Angel, Series A
- China
Portfolio highlights
- Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more
Investment focus
- Information Technology, Software, Financial Services
- Series B, Series A, Funding Round
- Japan, South Korea, United States
Portfolio highlights
- OPTEMO — OPTEMO develops and supplies sales technology that allows businesses and customers to connect through a website.
- Helical Fusion — Helical Fusion is a startup company that aims to commercialize fusion energy using magnetic confinement of high-temperature plasmas.
- Tokyo Artisan Intelligence — Tokyo Artisan Intelligence develops od purely domestic AI high-speed code generation tools as part of deep learning and hardware research. Their objectives are to contribute to the development of new computational technology and its application in society, particularly by providing experts through the training of doctoral students.
Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services.2) Agri-Food: Industrialization,agricultural and fishery products growth-promoting technology, specified health food, health food.3) Environment, Energy: Alternative energy, and related technologies.4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot.5) New services utilizing state-of-art technology.Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.
Show more
Investment focus
- Medical, Biotechnology, Information Technology
- Seed, Series A, Series B
- Japan, United States, United Kingdom
Portfolio highlights
- Peds3 — Peds3 is a digital healthcare platform that specializes in the research and development of pediatric medicine and maternal and child health fields.
- Oishii — Oishii Farm provides indoor vertical farming technology. Oishii sells via supermarkets, offering a container of between eight and 11 strawberries for $50 per package. Hiroki Koga and Brendan Somerville started the company in 2017.
- Innovative Space Carrier — Innovative Space Carrier is a aerospace company that offers space transportation systems, planning, drafting and technology strategies.
ASBV focuses on early and mid-term venture capital investments.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Angel
- China, Australia, Hong Kong
Portfolio highlights
- Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
- Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
- Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.
Show more
Investment focus
- Manufacturing, Biotechnology, Health Care
- Series A, Series B, Seed
- China, Singapore, Norway
Portfolio highlights
- TARS — Zhihang Zhong is a prominent researcher in the field of artificial intelligence, particularly known for his work on integrating spatial perception and reasoning into AI systems.
- Xinyanyi Code — Xinyanyi Code is an artificial intelligence programming application service provider that focuses on AI Coding and benchmarks the American intelligent code generation product Cursor.
- Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
- Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
- Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Taiwan
Portfolio highlights
- AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
- Hengyu Medical — Hengyu Medical is a medical device firm focused on R&D and production of IVUS and optical coherence tomography, and catheter equipment.
- Degron Therapeutics — Degron Therapeutics is a leading platform company in discovery of molecular glue degraders for cancer treatment.
CITIC Capital Holdings is an alternative investment management and advisory company headquartered in China.
Show more
Investment focus
- Manufacturing, Health Care, E-Commerce
- Series A, Series B, Series C
- China, United States, Japan
Portfolio highlights
- Xiaohongshu — Xiaohongshu is a lifestyle-sharing platform for users to share positive energy and good life through the sharing of text, pictures, and videos. Xiaohongshu offers an overseas shopping tip app. Xiaohongshu started its business by helping overseas travelers to draft a shopping list before they hit the roads. But with the aggregation of more UGCcontent, the service is transforming into a community for those who are passionate about fashion and shopping and want to know more about these fields even though they do not have overseas traveling plans on their schedules.
- Healthy Tree — Healthy Tree is a comprehensive solution provider for self-medication devices.
- Regional Fish — Regional Fish provides seed, seedlings, aquaculture methods and fisheries services.
ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.
Show more
Investment focus
- Manufacturing, Health Care, Medical
- Series A, Seed, Series B
- China, United States, India
Portfolio highlights
- Micot — Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, abiological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.
- Zhisheng Bio — Zhisheng Bio specialzies in product research and development, and market transformation of biopharmaceutical products.
- Prim Semiconductor — Prim Semiconductor specializes in ultra-high precision motion solutions, wafer transfer (EFEM), precision parts production, and comprehensive equipment research and development. The company focuses on providing integrated solutions across various sectors, including semiconductors, integrated circuit (IC) manufacturing, and new energy applications.
Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.
Show more
Investment focus
- Information Technology, Software, Artificial Intelligence
- Series A, Funding Round, Series B
- Japan, United States, Israel
Portfolio highlights
- ADiXi — Adixi is a tech-driven business that supports the idea that people and technology may work together. It strives to open doors by utilizing cutting-edge technology, such as artificial intelligence, to promote long-term, sustainable corporate and societal progress.
- OPERe — OPERe is an IT company that specializes in the development of semi autonomous hospitalization guidance solutions.
- Skygate Technologies — Founded in 2020, Skygate Technologies is building a network to deliver a large volume of data from observation satellites around the Earth to the ground and integrating the network into the web architecture. “Make Space accessible on the Web” is its motto, and the ability to develop both hardware and software is its strength. More information aboutSkygate Technologies can be found at www.skygate-tech.com.
Senshu Ikeda Capital offers financial consultancy services.
Show more
Investment focus
- Software, Internet, Information Technology
- Funding Round, Seed, Series A
- Japan
Portfolio highlights
- HOLO BIO — HOLO BIO is a research and technology firm that employs biological breeding techniques to address the food challenges faced by humanity.
- EX-Fusion — EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.
- Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.
Show more
Investment focus
- Information Technology, Software, Health Care
- Funding Round, Series A, Series B
- Japan, United States, Singapore
Portfolio highlights
- OPTEMO — OPTEMO develops and supplies sales technology that allows businesses and customers to connect through a website.
- Skygate Technologies — Founded in 2020, Skygate Technologies is building a network to deliver a large volume of data from observation satellites around the Earth to the ground and integrating the network into the web architecture. “Make Space accessible on the Web” is its motto, and the ability to develop both hardware and software is its strength. More information aboutSkygate Technologies can be found at www.skygate-tech.com.
- Phytolipid Technologies — Phytolipid Technologies specializes in the research and production of lipids in plants and algae and is an expert in lipid analysis.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Show more
Investment focus
- Biotechnology, Pharmaceutical, Health Care
- Series A, Series B, Series C
- United States, China, Israel
Portfolio highlights
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
- Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.
Show more
Investment focus
- Manufacturing, Software, Electronics
- Series A, Funding Round, Angel
- China
Portfolio highlights
- Songying Technology — Songying Technology focuses on the research and development of cloud-native real-time 3D engines and graphics collaboration platforms.
- Spectral Domain Technology — Spectral Domain Technology is a provider of 5G low-orbit broadband terminals, supplying operators, industrial Internet companies, satellite Internet, and government and enterprise customers with ocean communication needs.
- Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.
Show more
Investment focus
- Manufacturing, Semiconductor, Hardware
- Series A, Seed, Series B
- China, United States
Portfolio highlights
- Huachen Core Light — Huachen Core Light is a semiconductor technology company that produces and manufactures optical communications and laser chips.
- Beijing Ruidaen Technology Co. — Beijing Ruidaen Technology Co. is a manufacturer of target detection, radio interference, and laser electronic series.
- Northern Hemisphere Technology — Northern Hemisphere Technology is a high-tech company specializing in automotive-grade one-piece molded inductors. Northern Hemisphere focuses on high-performance and high-quality products, uses technology to serve customers and the market.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series B, Series A, Series C
- China, United States, South Korea
Portfolio highlights
- Easy Flow — Easy-Flow is committed to efficiently creating a complete set of solutions in the field of peripheral interventional devices.
- Force Inspiration — Force Inspiration is a start-up focusing on embodied intelligence technology. The company mainly engages in technology development, technical consulting, software development, basic artificial intelligence software development, information system integration services, intelligent robot research and development and sales, and industrial robotmanufacturing and sales.
- Core Medical Technology — Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.
EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies.
Show more
Investment focus
- Biotechnology, Software, Health Care
- Series C, Series B, Series D
- United States, Singapore, China
Portfolio highlights
- Antheia — Transforming pharmaceutical supply chains using synthetic biology, to end drug shortages and unlock new opportunities in development and discovery
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- Tacta Systems — Tacta Systems develops robotics with human-like tactile abilities with Dextrous Intelligence, the nervous system for robots.
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- Fine Vision — Fine Vision is a company with R&D facilities in Nanjing and Wuhan that focuses on femtosecond laser application research in the fields of ocular surgery and biomaterial processing. The entire femtosecond laser corneal refractive surgery equipment, its first commercially available item, was developed by the university's WuhanOptoelectronics National Research Center under the Huazhong Technology Technology transition.
- Stairway Medical — Stairway Medical is a developer of implantable brain-computer interface technology.
- Timberlyne Therapeutics — Taking Best-in-Class Therapies to New Heights Our mission is to bring life-changing medicines to patients living with autoimmune diseases. About Us Timberlyne Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of transformational therapies for autoimmune diseases. We are leveraging the extensive drug development expertise
Eisai is a pharmaceutical company that researches and delivers medicines for patients.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series C, Funding Round
- Japan, United States, China
Portfolio highlights
- Seed Therapeutics — Seed Therapeutics is a biotech company that focuses on harnessing and engineering molecules.
- Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
- Lifenet Insurance Company — LIFENET INSURANCE COMPANY offers a range of insurance underwriting and asset management solutions. Its insurance products include death, medical, and disability insurance. The company also provides health counselling services. LIFENET INSURANCE COMPANY was founded in October 2006.
Gaw Capital Partners is a positioned private equity fund management company that focuses in real estate markets in greater China and other high barrier-to-entry markets globally. Their services includes gateway real estate funds, separate account investments, venture capital, private equity investment and credit investments.
Show more
Investment focus
- Real Estate, Property Management, Hospitality
- Series A, Series C, Seed
- China, Singapore, United States
Portfolio highlights
- Placemakr — WhyHotel is an alternative lodging service company that operates pop-up hotels in newly built, luxury apartment buildings. The hotels offer fully furnished apartments that combine the comforts of home, the services of a hotel and the amenities of newly built, luxury apartment buildings. WhyHotel allows multifamily developers to de-risk the lease-upphase of new assets and creates a new revenue stream while serving as an added amenity for residents.
- Blackpanda — Asia's premier digital forensics and cyber incident response firm.
- NPX Point Avenue — NPX Point Avenue is an education technology company focused on the fast-growing K-12 private international school market and K-12 after-school training market.
Incubate Fund is an independent early-stage venture capital that specializes in providing capital to technology startups at the seed stage. The firm built a portfolio of over 300 companies in Asia, taking 12 companies to public and 20 companies to M&A exit since 2010.
Show more
Investment focus
- Software, Information Technology, E-Commerce
- Seed, Funding Round, Series A
- Japan, United States, India
Portfolio highlights
- Vieu — Learn about us, our team, our backers and the story behind Vieu.
- KOMPEITO — Office de Yasai is an online platform that enables users to order and get vegetables delivered to their offices. The platform’s operations are based in Tokyo, Japan.
- Phi — Build your web3 cities from your wallet activities
Tsinghua Capital is an investment firm.
Show more
Investment focus
- Manufacturing, Artificial Intelligence, Biotechnology
- Seed, Angel, Series A
- China, Australia
Portfolio highlights
- LightSail Technology — LightSail Technology is a professional Internet marketing service provider, focusing on Internet marketing and brand operation.
- Interstellar Lightyear — Interstellar Lightyear Technology is a developer specializing in dexterous robotic hands, focusing on creating intelligent dexterous hands with advanced capabilities for precise manipulation.
- CP Food Power Technology — CP Food Power Technology is a food technology company that specializes in smart food machine supply chain system solutions.
UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Funding Round
- Japan, United States, Singapore
Portfolio highlights
- Peach Cars — Buy or sell your car in Nairobi-Kenya with ease. Browse a wide range of vehicles, connect with trusted sellers, and find the perfect car today. Simple, fast, and secure transactions.
- Piece — Piece is a digital real estate platform offering the easiest and most transparent way to participate in income-producing real estate in Europe. Our mission is to make real estate ownership inclusive and more accessible.
- Forest — Forest Co., Ltd. operates as an e-commerce aggregator, seeks to identify sustainable, high-quality products and brands that embrace the spirit of Japan and help them grow and enter the global market by using the power of technology.
BOHE Angel Fund is an investment Fund.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Angel, Series A, Seed
- China
Portfolio highlights
- QuarkMed — QuarkMed is a nuclear medicine clinical CRO service company.
- Tyligand Bioscience — Tyligand Bioscience is a biotechnology company that focuses on the discovery and development of small molecule therapeutics to help patients with cancer and autoimmune diseases. Tyligand's pharmaceuticals are designed to target and treat tumors and autoimmune disorders, enabling healthcare professionals to prescribe more effective medicine andimprove health outcomes.
- Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
Lenovo Capital and Incubator Group is an accelerator and venture capital firm.
Show more
Investment focus
- Manufacturing, Artificial Intelligence, Software
- Series A, Series B, Seed
- China, Hong Kong, United States
Portfolio highlights
- DexForce — DexForce offers an AI-enabled robot with integrated 3D vision cameras, and software and hardware solutions for manufacturing robots.
- Lanxin Computing — Lanxin Computing is a high-performance chip design company that focuses on the research and development of CPUs with RISC-V ecosystems.
- Orbital Chenguang — Orbital Chenguang is a aerospace company that helps to launch and deploy deploy computing satellites into Earth's dawn and dusk orbits to construct a space data center committed to offering space-based computing services.
Yida China Holdings provides park development, park operation, construction, property management, landscaping, and decoration services. Their customers inquiries are addressed through phone, email, and online applications.
Show more
Investment focus
- Manufacturing, Semiconductor, Biotechnology
- Series A, Series B, Funding Round
- China, United States
Portfolio highlights
- Nasikey — Nasikey specializes in the research, development, production, and sales of core components for semiconductor equipment.
- Shengtai Nengke — Sunpower Group is an enterprise driven by green investment, based and supported by manufacturing and engineering services, and driven by R&D and innovation. Sunpower Group is headquartered in Nanjing, Jiangning.
- Atlan Technology — Atlan Technology focuses on the research and development, production and sales of composite high-performance fiber materials.
Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.
Show more
Investment focus
- Manufacturing, Software, Internet
- Series A, Series B, Series C
- China, India, United States
Portfolio highlights
- LibLib AI — LibLib AI is an AI image generation platform that provides cutting-edge content creation through multi-scenario and multi-dimensional applications and interactions. It is a subsidiary of Beijing Singularity Star Technology Co., Ltd.
- Huashen Ruili — Huashen Ruili is a manufacturer and retailer of auto parts. It focuses on the advancement of drive motor systems' dry brake-by-wire technology.
- Fanding International Group — Fanding International Group offers supply chain services by reducing logistics costs.
Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Japan
Portfolio highlights
- Sniper Medical Technology — Sniper develops accurate and intelligent molecular diagnostic solutions. Taking the next-generation fully automatic digital PCR as a breakthrough, the company has developed a droplet generation method with global independent intellectual property rights - Vibrant Injection technology and created a new path of chip-free droplet generationtechnology. It solves the pain points of high cost and complicated operation of microfluidic technology in practical application and is expected to bring subversive innovation in the field of refined medical testing.
- Xushui Internet — Xushui Internet provides image equipment monitoring, operation, and maintenance cloud services, large-scale equipment IoT management system, digital integration services for hospital-wide equipment, and remote collaborative image inspection system.
- Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.
Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.
Show more
Investment focus
- Software, Health Care, Information Technology
- Series B, Series A, Series C
- United States, China, India
Portfolio highlights
- Swan — Use Swan's APIs to embed white-labeled banking features like accounts, cards, and IBANs into your workflows and UX.
- BlissClub — BlissClub is the community's first women's activewear brand.
- Eleos Health — Eleos Health provides AI-powered, highly compliant documentation automation to ease the operational burden on behavioral healthcare providers.
Danen Ventures is an early-stage venture capital firm that focuses on high-growth fields, such as information technology and internet, renewable energy and environmental, advanced manufacturing industry, biotechnology and medical science, and healthcare.
Show more
Investment focus
- B2B, Fashion, Medical
- Series A, Angel, Seed
- China, United States
Portfolio highlights
- SynMetaBio — SynMetaBio is a company that develops synthetic biological materials, combining synthetic biology and material design. Their business modules include bio-based medical beauty, functional recombinant proteins, and medical aesthetic materials, including bionic bio-based leather.
- Meiyou Technology — Meiyou Technology is a DNA synthesizer developer focusing on enzymatic long-fragment DNA synthesis and splicing technology. They use high-throughput synthesizers to reduce DNA synthesis costs and offer gene design services for the biotechnology industry.
- 01 Life Science and Technology — Shenzhen is a high-tech firm dedicated to the application of human micro-ecological technology to develop solutions for a healthy life. It also offers solutions for clinical research and diagnosis and treatment of diseases. It was stablished in 2016 and is based in Shenzhen, Guangdong, China.
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Kenya
Portfolio highlights
- AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
- Kunwei Technology — Kunwei Technology manufactures high-precision force sensors (six-axis force sensors) as well as force control systems. It is involved in the research and development, manufacturing, sales, and technological promotion of intelligent force sensors, as well as the development of force sensor products for the robot and other intelligent equipmentindustries. It provides force measurement systems as well as goods connected to measurement and other industries.
- New Vision Medical — New Vision Medical is an IT infrastructure service provider that offers clinical trial-related digital platforms and services.
Orient Securities Capital Investment is an private equity fund business platform.
Show more
Investment focus
- Manufacturing, Health Care, Medical
- Series A, Funding Round, Series B
- China
Portfolio highlights
- Picea Motion — Picea Motion is a precision harmonic drive company that specializes in the development and production of harmonic speed reducers.
- Xinhui Lianxin — Xinhui Lianxin is an electronic component manufacturer, mainly engaged in the manufacturing of special equipment for semiconductor devices, semiconductor discrete devices, power electronic components, integrated circuit manufacturing, integrated circuit chips and product manufacturing.
- Haifu Technology — Haifu Technology is a high-tech company specializing in automobile manufacturing and robotics.
Starlight Capital provides investment and assistance to companies from the digital industry. It searches for businesses that are focusing on digital transformation and helps with its management. Starlight Capital is based in Shanghai, China.
Show more
Investment focus
- Manufacturing, Robotics, Software
- Series A, Series C, Series B
- China
Portfolio highlights
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
- Wanxun Technology — Wanxun Technology is a service robot developer dedicated to flexible, dexterous and interactive service robots for industries and families.
- Kedian Intelligent Cloud — Kedian Intelligent Cloud is an innovative enterprise focusing on the field of industrial hemp.
The Entrepreneurs Fund is a not-for-profit initiative launched by Alibaba Group in 2015 to help entrepreneurs and young graduates realize their dreams and vision. Two separate funds have been set up in Hong Kong and Taiwan respectively to support specific programs in each place.
Show more
Investment focus
- Software, E-Commerce, Artificial Intelligence
- Series A, Seed, Series B
- Hong Kong, Taiwan, United States
Portfolio highlights
- Vpon Holdings — Vpon Holdings is an AI big data analysis and advertising company.
- Ziwu Technology — Ziwu Technology offers the conversion of bio-based waste into sustainable new materials and provides environmentally friendly solutions.
- Rice Robotics Limited — The friendliest robot at your service.
Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.
Show more
Investment focus
- Software, Manufacturing, Information Technology
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Aiator — Aiator is an artificial intelligence product and technology solutions company focusing on industrial fields and biotechnology. Founded in 2010 by Silicon Valley Artificial Intelligence Scientist in Shenzhen Qianhai DreamWorks, the core members of the team are from the United States, the United Kingdom, Australia and Hong Kong. Currently, there arefour peacock talents and nearly 30 independent intellectual property rights. Weiai Intelligent is committed to carrying out AI empowerment services for enterprises, reducing costs and increasing efficiency.
- Qianxun Intelligence — Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.
- Gongjin Microelectronics — Gongjin Microelectronics develops and manufactures electronic components and semiconductor solutions for various industries.
Puhua Capital is an equity investment firm that focuses on early and middle project.
Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.
Show more
Investment focus
- Health Care, Medical, Manufacturing
- Series A, Series B, Seed
- China, United Kingdom, United States
Portfolio highlights
- Yifei Aviation — Yifei Aviation manufactures intelligent unmanned aerial vehicles (UAVs). Its primary business scope includes intelligent unmanned aerial vehicle manufacture, sales, and other services.
- LuMing Robotics — LuMing Robotics is a developer of intelligent robots. LuMing Robotics focuses on the field of embodied intelligent robots, and its business covers intelligent robot R&D and sales, artificial intelligence algorithm development, etc.
- Rongrui Technology — Rongrui Technology is an industrial enzyme developer, involved in industrial enzyme research and development; technical services, technology development, technology consulting, technology exchange, technology transfer, and technology promotion.
Investors by industry
Consumer
Proptech
Impact
Climate
Gaming
Biotech
FinTech
Marketplace
Community
Health Care
Hardware
EdTech
Sustainability
Venture Capital
Real Estate
Photography
Clean Energy
Education
B2B
Financial Services
Energy
Artificial intelligence
Google
Music
Art
Wellness
Franchise
Big Data
Payments
Finance
Mobile
Organic Food
Local
Food and Beverage
Web3
Digital Media
Infrastructure
Legal
Retail
Android
Beauty
Publishing
eSports
Video Games
Hospitality
Enterprise Software
Platforms
Sports
Biotechnology
Cannabis
Manufacturing
Mobile Advertising
Email
Travel
Medical
Fitness
Social Network
Recruiting
Social Media
Crowdfunding
Social
Internet
Medical Device
Construction
Automotive
CleanTech
Wine And Spirits
Mobile Apps
InsurTech
Transportation
Enterprise
LGBT
Life Science
Fashion
Oil and Gas
Theatre
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Celebrity
Social Impact
Software
Cryptocurrency
Blockchain
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Investors by country
Canada
Germany
United Kingdom
Ireland
South Korea
India
Australia
New Zealand
United States
Middle East
Brazil
LATAM
Qatar
Indonesia
Asia
Europe
Spain
South Africa
Singapore
Armenia
Saudi Arabia
Sri Lanka
China
Africa
Oceania
Japan
Vietnam
Belarus
Chile
Belgium
Hong Kong
Finland
Ghana
Georgia
Ethiopia
Gibraltar
Faroe Islands
Denmark
Egypt
Estonia
Costa Rica
Hungary
Greece
Barbados
Croatia
Belize
Bahrain
Czech Republic
Algeria
Ecuador
Bulgaria
Bermuda
France
Kuwait
Malta
Morocco
Nicaragua
Mali
Lithuania
Peru
Lebanon
Jersey
Norway
Myanmar
Mauritius
Liberia
Mexico
Malaysia
Liechtenstein
Philippines
Italy
Israel
Poland
Senegal
Sierra Leone
Tunisia
Togo
Serbia
Turkey
San Marino
Thailand
Uzbekistan
Taiwan
Panama
Sweden
Dominican Republic
Nigeria
Tanzania
Slovenia
Iraq
Azerbaijan
Bahamas
El Salvador
Portugal
Iceland
Tajikistan
Ukraine
Namibia
United Arab Emirates
Jamaica
Honduras
Puerto Rico
Bolivia
Uganda
Isle of Man
Luxembourg
Venezuela
Uruguay
Zambia
Albania
Zimbabwe
Pakistan
Rwanda
Russian Federation
Kazakhstan
Grenada
Jordan
Bangladesh
Argentina
Romania
Kenya
Cayman Islands
Cambodia
Latvia
Cyprus
Oman
Cameroon
Austria
Switzerland
Colombia
Guatemala
Seychelles
Marshall Islands
Investors in Asia by industry
Restaurants
Crowdfunding
Venture Capital
Film
Mobile Advertising
B2B
Mobile Apps
Cryptocurrency
Finance
Payments
Food and Beverage
Video Games
Wine And Spirits
Medical Device
Email
Internet
Social Network
Social Media
Digital Media
Manufacturing
Art
Mobile
Android
Local
Google
Software
Construction
Sports
Legal
Enterprise Software
eSports
Fitness
Automotive
CleanTech
Travel
Hospitality
Recruiting
Platforms
Biotechnology
FinTech
Enterprise
Health Care
Real Estate
Biotech
Consumer
Climate
Energy
Impact
Sustainability
Proptech
Marketplace
Hardware
SaaS
Community
Social Impact
Gaming
Social
Retail
Infrastructure
Fashion
Beauty
Sporting Goods
Web3
Photography
Publishing
Big Data
Medical
Renewable Energy
Clean Energy
Oil and Gas
Financial Services
Transportation
Non Profit
Wellness
EdTech
Blockchain
Theatre
Education
Franchise
Life Science
Music
Media (entertainment)
Agriculture (agtech)
Machine Learning
Organic Food
InsurTech
Artificial intelligence